4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-428018
Chief Financial Officer bought 5,500 shares at $26.10 ($143,550)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ignelzi Troy A. Chief Financial Officer | 2026-10-21 | Purchase | +5,500 | $26.10 | $143,550 | 15,500 | D |
| Open-market purchases · 5,500 sh · avg $26.10 · $143,550 | |||||||
Loading xslF345X06/ownership.xml…